Programs
Continuing Medical Education (CME) Programs
Upcoming programs
Live CME program on eosinophilic esophagitis (EoE) on Friday, Sept. 29 at 11 a.m. ET
Join us for a live CME program on diagnosing and managing EoE, “Enhancing Diagnosis and Access to Treatment in EoE: What You Need to Know from Your Patients.” An expert panel of gastroenterologists will:
- Provide guidance on EoE diagnosis
- Discuss the importance of asking questions to uncover adaptive behaviors
- Share details of the current treatment paradigm
Participating clinicians will learn about evidence-based guidelines, expert recommendations, and data on new targeted agents for EoE.
Register now for the live program, or you can watch on demand later.
CME Programs on Asthma and Allergy
View our programs on asthma and allergy below. You can earn an AMA PRA Category 1 Credit™, as noted.
At the Forefront of Food Allergies: Preventive Strategies to Improve Outcomes
Available on demand starting Sept. 20. Topics discussed during this program include:
- The changing landscape of food allergy management
- Newer approaches to enhance food allergen tolerance
- The key roles of patients and their families when making therapeutic decisions
Earn AMA PRA Category 1 Credit™ through Sept. 20, 2024. Watch on demand.
Applying Guidelines and Latest Evidence to the Management of Moderate‐to‐Severe Asthma in Children and Adults
Topics discussed during this course include:
- The impact of moderate-to-severe asthma on airway remodeling and lung development in children
- Conditions that occur frequently with asthma
- Strategies to develop personalized asthma treatment plans
Earn AMA PRA Category 1 Credit™ through July 20, 2024. Watch on demand.
Applying the Latest Guidelines and Recommendations to Initiate Biologic Therapy and Control Moderate-to-Severe Asthma Symptoms
Topics discussed during this course include:
- The burden of uncontrolled asthma
- The impact of asthma phenotypes/endotypes and type 2 comorbidities
- Current data on the efficacy and safety of biologics
Earn AMA PRA Category 1 Credit™ through Nov. 29, 2023. Watch on demand.
Biologic Therapy for Patients with Severe Asthma: Impeding the Inflammatory Cascade
- Roles of various inflammatory pathways in severe asthma
- Mechanisms of action of various therapies and their safety and efficacy data
- How a new treatment option targeting TSLP can be integrated into asthma management plan
Earn AMA PRA Category 1 Credit™ through Aug. 23, 2023. Watch on demand.
TARGETING ASTHMA: Community-based Strategies to Enhance Care Access for Children, Adolescents, and Adults – Focus on Social Determinants of Health and Inequities of Care
Topics discussed during this course include:
- Strategies to enhance access to individualized care among people of racial and ethnic minorities
- How to identify patients with moderate-to-severe asthma who may benefit from targeted biologic agents
- How to identify the place of type-2-targeted biologics in the management of moderate-to-severe asthma
Please note the AMA PRA Category 1 Credit™ is no longer available.
CME Programs on Allergic Conditions
View our programs on allergic conditions such as chronic spontaneous urticaria (CSU), eosinophilic esophagitis (EoE), atopic dermatitis (AD), and more. You can earn an AMA PRA Category 1 Credit™, as noted.
Caring for Patients with Nasal Polyps in 2023: When to Consider a Biologic or Surgery?
Topics covered during this course include:
- The latest understanding of chronic rhinosinusitis with nasal polyps (CRSwNP), or nasal polyps
- People at high risk for recurrence of nasal polyps
- Treatment options for people with nasal polyps
Earn AMA PRA Category 1 Credit™ through Oct. 12, 2024. Watch on demand.
Chronic Spontaneous Urticaria: New Hope with Emerging Targeted Agents
- The latest in chronic spontaneous urticaria (CSU) treatment options
- Management and treatment escalation standards
- Perspectives from the patient journey
Please note the AMA PRA Category 1 Credit™ is no longer available.
Disparity and Equity in Moderate-to-Severe AD Care: Enhancing Access to Multidisciplinary Care for Patients from Diverse Populations
Topics covered during this course include:
- The impacts that age, race, and ethnicity have on atopic dermatitis (AD)
- Management of moderate-to-severe atopic dermatitis
- The unique challenges that people from diverse racial and ethnic group face when attempting to access care
Earn AMA PRA Category 1 Credit™ through Oct. 24, 2023. Watch on demand.
Endophenotypes, Evidence, and Long-Term Outcomes in Moderate-to-Severe Atopic Dermatitis Management: A Decision Library
Topics covered during this course include:
- Alignment of therapeutic decisions to clinical endophenotypes in patients of different age groups and races
- Evidence-based treatment recommendations to achieve long-term disease control
- Strategies to encourage shared-decision-making with patients
Earn AMA PRA Category 1 Credit™ through Oct. 24, 2023. Watch on demand.
Eosinophilic Esophagitis: Guidelines and Emerging Evidence for Effective Management Strategies
Topics discussed during this course include:
- How to recognize the symptoms of eosinophilic esophagitis (EoE) across a variety of patient ages to facilitate an early diagnosis
- Emerging data on new, more efficient, targeted agents for the management of EoE
Please note the AMA PRA Category 1 Credit™ is no longer available.
The Increasing Importance of Identifying Urticaria Subtypes to Achieve Control: Opportunities with T2 Inflammation Targeting Agents
Topics discussed during this course include:
- The relationships between chronic inducible urticaria (CIndU) triggers and underlying pathophysiologic pathways
- How to optimize treatment of chronic spontaneous urticaria (CSU) and CIndU
- Strategies to identify urticaria subtypes
Earn AMA PRA Category 1 Credit™ through Jan. 9, 2024. Watch on demand.
Moving Toward a Targeted Approach for Nasal Polyps
Topics discussed during this course include:
- The patient burden of nasal polyps
- Limitations of traditional nasal polyp treatments and emerging therapies for those with nasal polyps
- Rationale for targeted approaches to nasal polyp management
Please note the AMA PRA Category 1 Credit™ is no longer available.
Multidisciplinary Approach to the Management of CRS with Refractory Nasal Polyps: ENT, Allergist, and Patient Partnerships to Enhance Care and QoL
- Patient-centered treatment options for chronic rhinosinusitis with nasal polyps (CRSwNP)
- Disease burden
- The impacts that biologics and surgery have on symptoms and quality of life (QoL)
Earn AMA PRA Category 1 Credit™ through Oct. 21, 2023. Watch on demand.
